Wednesday, September 7, 2016

Senate investigations panel to probe Mylan's EpiPen pricing

WASHINGTON, Sept 7 (Reuters) - The U.S. Senate's permanent

subcommittee on investigations has decided to look into Mylan

Pharmaceuticals' pricing of the EpiPen, according to a press

release issued on Wednesday.

Read more

No comments:

Post a Comment